Skip to main content

RETRACTION article

Front. Oncol., 30 December 2021
Sec. Cancer Genetics
Volume 11 - 2021 | https://doi.org/10.3389/fonc.2021.839904

Retraction: Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1

This article is a retraction of:

  1. RETRACTED: Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1

    1. Read original article
Frontiers Editorial Office* Frontiers Editorial Office*

    A Retraction of the Original research Article
    Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1

    By Pan X., Hong X., Lai J., Cheng L., Cheng Y., Yao M., Wang R. and Hu N. (2020) Front. Oncol. 10:441. doi: 10.3389/fonc.2020.00441

    The journal and Chief Editors retract the 30 April 2020 article cited above.

    Following publication, concerns were raised regarding the validity of the data in the article. The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns, and the lack of raw data, the editors no longer have confidence in the findings presented in the article. ​

    This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers. The authors have not responded to any correspondence regarding the retraction.

    Citation: Frontiers Editorial Office (2021) Retraction: Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1. Front. Oncol. 11:839904. doi: 10.3389/fonc.2021.839904

    Received: 20 December 2021; Accepted: 20 December 2021;
    Published: 30 December 2021.

    Approved by:

    Giuseppe Giaccone, Cornell University, United States

    Copyright © 2021 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    *Correspondence: Frontiers Editorial Office, ZWRpdG9yaWFsLm9mZmljZUBmcm9udGllcnNpbi5vcmc=

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.